Journal: European Heart Journal Open
Article Title: Modulation of cell fate by shock wave therapy in ischaemic heart disease
doi: 10.1093/ehjopen/oeaf011
Figure Lengend Snippet: Shockwave therapy induces transdifferentiation via Toll-like receptor 3. ( A ) Expression of the innate immune receptor Toll-like receptor 3 on human cardiac fibroblasts. green = Toll-like receptor 3; blue = DAPI. Scale bar = 20 µm. ( B ) Toll-like receptor 3 activation of Toll-like receptor 3 reporter cells upon shockwave therapy or Poly(I:C) treatment (30 ng/mL). Data are means ± SEM. ** P < 0.01. ( C ) The expression of the downstream adapter TIR-domain-containing adapter-inducing interferon-β after shockwave therapy or Poly(I:C) treatment (30 ng/mL). ( D ) mRNA levels of interleukin-6 after shockwave therapy or Poly(I:C) treatment (30 ng/mL). Data are means ± SEM. * P < 0.01. ( E ) Human fibroblasts were treated with shockwave therapy in the presence of endothelial induction medium containing bone morphogenetic protein 4, vascular endothelial growth factor, and fibroblast growth factor and subjected to reverse transcription polymerase chain reaction (RT-PCR) or fluorescence-activated cell sorting. ( F ) mRNA expression of CD31 after treatment with control medium, endothelial induction medium, shockwave therapy, or a specific dsRNA/Toll-like receptor 3 inhibitor. Data are means ± SEM. ** P < 0.01. ( G ) mRNA expression of VEGF receptor 2 after treatment with control medium, endothelial induction medium, shockwave therapy, or a specific dsRNA/Toll-like receptor 3 inhibitor. Data are means ± SEM. * P < 0.05. ( H ) mRNA expression of vascular endothelial cadherin after treatment with control medium, endothelial induction medium, shockwave therapy, or a specific dsRNA/Toll-like receptor 3 inhibitor. Data are means ± SEM. ** P < 0.01. ( I ) Fluorescence-activated cell sorting for CD31 after treatment with shockwave therapy or a combined treatment with a specific dsRNA/Toll-like receptor 3 inhibitor and shockwave therapy. Statistical comparisons between multiple groups: one-way analysis of variance with Tukey post hoc analysis. ALP, alkaline phosphatase; BMP4, bone morphogenetic protein 4; CTRL, control; EIM, endothelial induction medium; FACS, fluorescence-activated cell sorting; FGF, fibroblast growth factor; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; IL-6, interleukin-6; SWT, shockwave therapy; TLR3, Toll-like receptor 3; TLR3inh, TLR3 inhibitor; TRIF, TIR-domain-containing adapter-inducing interferon-β; VE-cadherin, vascular endothelial cadherin; VEGF, vascular endothelial growth factor; VEGFR2, VEGF receptor 2.
Article Snippet: BJ human newborn foreskin fibroblasts (ATCC, Washington, DC, USA) were cultured and maintained in DMEM with 10% FCS and 1% penicillin/streptomycin/glutamine at 37°C and 5% CO 2 .
Techniques: Expressing, Activation Assay, Reverse Transcription, Polymerase Chain Reaction, Reverse Transcription Polymerase Chain Reaction, Fluorescence, FACS, Control